{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:29:30Z","timestamp":1777566570552,"version":"3.51.4"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejphar.2021.173961","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T21:25:02Z","timestamp":1613856302000},"page":"173961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Sex differences in heart failure medications targeting the renin-angiotensin-aldosterone system"],"prefix":"10.1016","volume":"897","author":[{"given":"Persoulla A.","family":"Nicolaou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejphar.2021.173961_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0003319715607298","article-title":"Sex differences in patients with acute decompensated heart failure: insights from the heart function assessment registry trial in Saudi Arabia","volume":"67","author":"AlFaleh","year":"2016","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib2","doi-asserted-by":"crossref","first-page":"F934","DOI":"10.1152\/ajprenal.00145.2002","article-title":"Estrogen upregulates renal angiotensin II AT(2) receptors","volume":"283","author":"Armando","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173961_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00004872-199715070-00003","article-title":"Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys","volume":"15","author":"Brosnihan","year":"1997","journal-title":"J. Hypertens."},{"issue":"14","key":"10.1016\/j.ejphar.2021.173961_bib4","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2165\/00003495-200161140-00002","article-title":"Underutilisation of ACE inhibitors in patients with congestive heart failure","volume":"61","author":"Bungard","year":"2001","journal-title":"Drugs"},{"issue":"7031","key":"10.1016\/j.ejphar.2021.173961_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1755-5922.2009.00094.x","article-title":"Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure","volume":"27","author":"Chaggar","year":"2009","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2021.173961_bib7","doi-asserted-by":"crossref","first-page":"307315","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-converting enzyme 2: the first decade","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int. J. Hypertens."},{"issue":"23","key":"10.1016\/j.ejphar.2021.173961_bib8","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"10120","key":"10.1016\/j.ejphar.2021.173961_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00004872-199816060-00017","article-title":"Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans","volume":"16","author":"Danser","year":"1998","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-62-3-536","article-title":"Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration","volume":"62","author":"De Lignieres","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib12","doi-asserted-by":"crossref","first-page":"R759","DOI":"10.1152\/ajpregu.00595.2004","article-title":"17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats","volume":"288","author":"Dean","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/hy1101.096114","article-title":"Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy","volume":"38","author":"Deinum","year":"2001","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173961_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0024-3205(93)90245-X","article-title":"The influence of reproductive hormones on ANF release by rat atria","volume":"53","author":"Deng","year":"1993","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0008-6363(01)00479-5","article-title":"Renin angiotensin system and gender differences in the cardiovascular system","volume":"53","author":"Fischer","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1470320313497328","article-title":"Review of direct renin inhibition by aliskiren","volume":"14","author":"Friedrich","year":"2013","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00005082-200511000-00013","article-title":"ADHERE Scientific Advisory Committee (SAC) Investigators, Coordinators, and Study Group. Reshaping our perception of the typical hospitalized heart failure patient: a gender analysis of data from the ADHERE Heart Failure Registry","volume":"20","author":"Galvao","year":"2005","journal-title":"J. Cardiovasc. Nurs."},{"issue":"18","key":"10.1016\/j.ejphar.2021.173961_bib19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"J. Am. Med. Assoc."},{"issue":"10159","key":"10.1016\/j.ejphar.2021.173961_bib20","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejphar.2021.173961_bib21","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/archinte.1989.00390120061012","article-title":"Enalapril-induced cough","volume":"149","author":"Gibson","year":"1989","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173961_bib22","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.HYP.0000102180.13341.50","article-title":"Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity","volume":"42","author":"Harrison-Bernard","year":"2003","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.0000157161.78721.5c","article-title":"Estradiol induces discordant angiotensin and blood pressure responses to orthostasis in healthy postmenopausal women","volume":"45","author":"Harvey","year":"2005","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173961_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.76.4.753","article-title":"The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure","volume":"76","author":"Hassager","year":"1987","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ehf2.12347","article-title":"Gender differences in Egyptian patients hospitalized with heart failure: insights from the European society of cardiology heart failure long-term registry","volume":"5","author":"Hassanein","year":"2018","journal-title":"ESC Heart Fail."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173961_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.HYP.33.2.613","article-title":"Recent progress in angiotensin II type 2 receptor research in the cardiovascular system","volume":"33","author":"Horiuchi","year":"1999","journal-title":"Hypertension"},{"issue":"6\u20137","key":"10.1016\/j.ejphar.2021.173961_bib31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejheart.2007.02.001","article-title":"Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study","volume":"9","author":"Hudson","year":"2007","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173961_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjhyper.2005.10.006","article-title":"Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women","volume":"19","author":"Ichikawa","year":"2006","journal-title":"Am. J. Hypertens."},{"issue":"17","key":"10.1016\/j.ejphar.2021.173961_bib33","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2014-306775","article-title":"The neprilysin pathway in heart failure: a review and guide on the use of sacubitril\/valsartan","volume":"102","author":"Jhund","year":"2016","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1440-1843.1998.d01-7.x","article-title":"Molecular studies of bronchial asthma, sarcoidosis and angiotensin converting enzyme inhibitor-induced cough","volume":"3","author":"Kawakami","year":"1998","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173961_bib35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/gme.0b013e31806548f6","article-title":"B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram","volume":"15","author":"Kawano","year":"2008","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cardiores.2006.09.006","article-title":"ACE2 of the heart: from angiotensin I to angiotensin (1-7)","volume":"73","author":"Keidar","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","article-title":"The pathophysiology of heart failure","volume":"21","author":"Kemp","year":"2012","journal-title":"Cardiovasc. Pathol."},{"issue":"9","key":"10.1016\/j.ejphar.2021.173961_bib38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1515\/cclm-2013-0791","article-title":"Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care","volume":"52","author":"Keyzer","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"issue":"18","key":"10.1016\/j.ejphar.2021.173961_bib39","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.110.979500","article-title":"Natriuretic peptide testing in heart failure","volume":"123","author":"Kim","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin-angiotensin-aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"9704","key":"10.1016\/j.ejphar.2021.173961_bib41","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"HEAAL Investigators. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173961_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators","volume":"86","author":"Konstam","year":"1992","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173961_bib43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0002-8703(96)90365-8","article-title":"Adverse effects of enalapril in the studies of left ventricular dysfunction (SOLVD). SOLVD investigators","volume":"131","author":"Kostis","year":"1996","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ejhf.1645","article-title":"European society of cardiology heart failure long-term registry investigators group. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP heart failure long-term registry","volume":"22","author":"Lain\u0161\u010dak","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib45","first-page":"352","article-title":"Gender differences in serum angiotensin-converting enzyme activity and blood pressure in children: an observational study","volume":"91","author":"Landazuri","year":"2008","journal-title":"Arq. Bras. Cardiol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173961_bib46","first-page":"271","article-title":"Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues","volume":"2","author":"Lazard","year":"1994","journal-title":"Recept. Channel"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2006.099523","article-title":"Management of patients with heart failure in clinical practice: differences between men and women","volume":"94","author":"Lenzen","year":"2008","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.ejphar.2021.173961_bib48","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1016\/S0021-9258(17)34622-7","article-title":"Direct inhibition of tyrosine hydroxylase activity by catechol estrogens","volume":"253","author":"Lloyd","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.173961_bib49","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1999.00855.x","article-title":"Cough and angiotensin II receptor antagonists: cause or confounding?","volume":"47","author":"Mackay","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173961_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000150977","article-title":"Estrogen reduces aldosterone, upregulates adrenal angiotensin II AT2 receptors and normalizes adrenomedullary Fra-2 in ovariectomized rats","volume":"88","author":"Macova","year":"2008","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/cs1010447","article-title":"Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women","volume":"101","author":"Maffei","year":"2001","journal-title":"Clin. Sci. (Lond.)"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib53","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4081\/monaldi.2018.988","article-title":"The impact of gender in cardiovascular medicine: Lessons from the gender\/sex-issue in heart failure","volume":"88","author":"Marra","year":"2018","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/eurjhf\/hfs026","article-title":"Squire I; Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC). Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis","volume":"14","author":"Mart\u00ednez-Sell\u00e9s","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.ejphar.2021.173961_bib55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/FPC.0b013e328348c6db","article-title":"Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes","volume":"21","author":"Mas","year":"2011","journal-title":"Pharmacogenetics Genom."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/phrs.1997.0202","article-title":"No sex-related pharmacokinetic and pharmacodynamic differences of captopril","volume":"36","author":"Massana","year":"1997","journal-title":"Pharmacol. Res."},{"issue":"23","key":"10.1016\/j.ejphar.2021.173961_bib57","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ejphar.2021.173961_bib58","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1523-1755.1999.00260.x","article-title":"Impact of gender on the renal response to angiotensin II","volume":"55","author":"Miller","year":"1999","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173961_bib61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a Comprehensive review","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejphar.2021.173961_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/ENDO:24:2:161","article-title":"Vascular responses to Angiotensin-(1-7) during the estrous cycle","volume":"24","author":"Neves","year":"2004","journal-title":"Endocrine"},{"issue":"22","key":"10.1016\/j.ejphar.2021.173961_bib63","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.97.22.2197","article-title":"Estrogen modulates AT1 receptor gene expression in vitro and in vivo","volume":"97","author":"Nickenig","year":"1998","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ejphar.2021.173961_bib64","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1161\/CIRCULATIONAHA.106.673442","article-title":"CHARM Investigators. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"115","author":"O'Meara","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib65","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ejheart.2003.11.021","article-title":"The 'real' woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists","volume":"6","author":"Opasich","year":"2004","journal-title":"Eur. J. Heart Fail."},{"issue":"8789","key":"10.1016\/j.ejphar.2021.173961_bib66","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0140-6736(92)91694-4","article-title":"Female sex as an important determinant of lisinopril-induced cough","volume":"339","author":"Os","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib67","first-page":"94","article-title":"In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET","volume":"45","author":"Owonikoko","year":"2004","journal-title":"J. Nucl. Med."},{"issue":"23","key":"10.1016\/j.ejphar.2021.173961_bib68","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.173961_bib69","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib70","doi-asserted-by":"crossref","first-page":"H10","DOI":"10.1152\/ajpheart.01277.2007","article-title":"Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats","volume":"295","author":"Pendergrass","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"17","key":"10.1016\/j.ejphar.2021.173961_bib71","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.99.17.2334","article-title":"Failure of women's hearts","volume":"99","author":"Petrie","year":"1999","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejphar.2021.173961_bib72","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"9215","key":"10.1016\/j.ejphar.2021.173961_bib73","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ejphar.2021.173961_bib74","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ejphar.2021.173961_bib75","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173961_bib76","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"8967","key":"10.1016\/j.ejphar.2021.173961_bib77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(95)92114-1","article-title":"Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women","volume":"346","author":"Proudler","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MNH.0b013e3282f357da","article-title":"Renal hemodynamics in heart failure: implications for treatment","volume":"17","author":"Rea","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib79","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrd2032","article-title":"Therapeutic implications of the gender-specific aspects of cardiovascular disease","volume":"5","author":"Regitz-Zagrosek","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.ejphar.2021.173961_bib81","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/endo.141.12.7822","article-title":"Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats","volume":"141","author":"Roesch","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2021.173961_bib82","first-page":"e18","article-title":"Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"issue":"40","key":"10.1016\/j.ejphar.2021.173961_bib83","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/eurheartj\/ehv161","article-title":"Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC","volume":"36","author":"Rosano","year":"2015","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173961_bib84","first-page":"533","article-title":"Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril","volume":"18","author":"S\u00e1enz-Campos","year":"1996","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"10205","key":"10.1016\/j.ejphar.2021.173961_bib85","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(19)31792-1","article-title":"Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study","volume":"394","author":"Santema","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib86","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","article-title":"Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women","volume":"95","author":"Schunkert","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173961_bib88","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0002-9343(00)00529-5","article-title":"Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry","volume":"109","author":"Shah","year":"2000","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"17","key":"10.1016\/j.ejphar.2021.173961_bib90","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"PARAGON-HF investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173961_bib91","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yjmcc.2006.04.019","article-title":"17beta-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts","volume":"41","author":"Stewart","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib92","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1291\/hypres.26.369","article-title":"Effects of hormone replacement therapy on office and ambulatory blood pressure in Japanese hypertensive postmenopausal women","volume":"26","author":"Sumino","year":"2003","journal-title":"Hypertens. Res."},{"issue":"8875","key":"10.1016\/j.ejphar.2021.173961_bib15","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","author":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173961_bib93","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1183\/09031936.93.06040576","article-title":"Kinins and respiratory tract diseases","volume":"6","author":"Trifilieff","year":"1993","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173961_bib94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/hr.2009.199","article-title":"JCARE-CARD Investigators. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure","volume":"33","author":"Tsuchihashi-Makaya","year":"2010","journal-title":"Hypertens. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2021.173961_bib95","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"American heart association Council on epidemiology and prevention statistics Committee and stroke statistics subcommittee. Heart disease and stroke statistics-2020 update: a report from the American heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.173961_bib96","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1100\/tsw.2003.121","article-title":"Differences between lovastatin and simvastatin hydrolysis in healthy male and female volunteers:gut hydrolysis of lovastatin is twice that of simvastatin","volume":"3","author":"Vree","year":"2003","journal-title":"Sci. World J."},{"issue":"11","key":"10.1016\/j.ejphar.2021.173961_bib97","first-page":"1254","article-title":"Sex-based differences in drug activity","volume":"80","author":"Whitley","year":"2009","journal-title":"Am. Fam. Physician"},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2021.173961_bib98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejphar.2009.05.016","article-title":"17beta-estradiol inhibits angiotensin II-induced cardiac myofibroblast differentiation","volume":"616","author":"Wu","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173961_bib99","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/en.2003-0015","article-title":"Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation","volume":"144","author":"Wu","year":"2003","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173961_bib100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ahj.2008.12.016","article-title":"Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF","volume":"157","author":"Yancy","year":"2009","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173961_bib101","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00005344-200405000-00018","article-title":"Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers","volume":"43","author":"Zapater","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:49:04Z","timestamp":1757976544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":101,"alternative-id":["S001429992100114X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173961","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in heart failure medications targeting the renin-angiotensin-aldosterone system","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173961"}}